ACT-AD to Hold Annual FDA/AD Allies Meeting on Combination Therapies
Next month, ACT-AD will offer an opportunity for patient groups, researchers and industry to interact with the FDA on how to best foster more robust pre-competitive collaboration in Alzheimer’s disease in order to encourage the development of combination therapies. This meeting will explore the challenges of these collaboration and potential opportunities for future partnership. Individuals involved in current and past collaborative efforts, will reflect upon their experiences and prescriptions for the field moving forward. Presentations will be followed by a panel discussion.
The meeting is a public event that is co-hosted by The Critical Path Institute. It will be held on November 29, 2012 from 7:30 a.m. to 2:00 p.m. at the Hilton Rockville Executive Meeting Center in Rockville, MD. There is no fee to attend and all ACT-AD members are encouraged to participate.
To RSVP for the meeting, please email Dina Beaumont at [email protected]
NAPA Holds October Advisory Council Meeting
The Advisory Council on Alzheimer’s Research, Care, and Services, tasked with guiding the National Alzheimer’s Project Act, held its sixth meeting on October 15 in Washington, DC. The meeting included reports from a number of federal officials leading the implementation of the National Plan to Address Alzheimer’s Disease. Their reports addressed the current progress of a number of federal workgroups, and the overarching goals and priorities for 2013 recommendations.
This meeting also incorporated an update on research of interest to the NAPA board via the International Alzheimer’s Disease Research Portfolio (IADRP), as well as a discussion regarding recommendations made by the Long Term Services and Supports Subcommittee.
All slides used during the meeting are available to the public, and can be viewed here.
FDA Holds First Public Meeting on Patient-Focused Drug Development
On October 25, the US Food and Drug Administration (FDA) held a public meeting at its White Oak Campus to provide an overview of the new Patient-Focused Drug Development initiative mandated by the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012. The program is an attempt to better obtain and utilize the patient’s own perspective on their particular disease areas, and in particular, their aversion to risk when it comes to developing therapies. ACT-AD was represented at this meeting and comments were made by Cynthia Bens, Vice President of Public Policy for the Alliance for Aging Research urging FDA to continuing making Alzheimer’s disease a priority.
FDA will convene 20 meetings over the next five years, each focusing on a different disease area, reviewing the complete range of materials available for each indication and identifying areas of unmet need. The meetings are comprised of the appropriate review divisions, the relevant patient advocacy communities and other interested parties, and focus on the patient perspective regarding two key considerations in FDA’s regulatory decision-making: the severity of the disease and the currently available treatment options.
For more information on the FDA’s Patient-Focused Drug Development initiative, click here.
The Alzheimer’s Foundation of America to Host 10th Annual National Memory Screening Day
In honor of National Alzheimer’s Awareness Month, the Alzheimer’s Foundation of America, an ACT-AD member, is sponsoring its 10th annual National Memory Screening Day. On November 13, 2012 community sites nationwide will offer free, confidential memory screenings and educational materials to the public.
During the National Memory Screening Day, five to ten minute face-to-face screenings are administered by qualified healthcare professionals (i.e., physicians, psychologists, nurses, nurse practitioners, social workers, pharmacists). Screening sites include Alzheimer’s agencies, assisted living residences, long-term care facilities, doctors’ offices, hospitals, senior centers, YMCA’s, pharmacies and other local venues.
In 2011, 96,500 people participated at 2,540 community sites nationwide. To assist in this year’s National Memory Screening Day you can host a screening site, offer to be a screener, encourage people with memory concerns to be screened, or spread the word.
For more information visit www.nationalmemoryscreening.org.